Increased risk for gastric cancer in carriers of the lymphotoxin-α+252G variant infected by Helicobacter pylori

Genet Test Mol Biomarkers. 2012 Jan;16(1):9-14. doi: 10.1089/gtmb.2011.0078. Epub 2011 Jul 27.

Abstract

The objective of this study is to determine whether polymorphisms in the lymphotoxin-α (LTA) and interleukin-10 (IL-10) genes were associated with gastric cancer (GC) in a Chinese population. One hundred ninety-six patients with GC and 248 healthy individuals were enrolled in this case-control study. The LTA 252G was associated with an increased risk of GC, with an adjusted odds ratio (OR) of 1.74 (95% confidence interval [CI]: 1.12-2.69) for the LTA 252G heterozygotes and 2.42 (95% CI: 1.28-4.58) for the LTA 252G homozygotes as compared with noncarriers. In contrast, such association is not found in polymorphisms in IL-10; however, a potential interaction between LTA +252 G allele and IL-10-1082 G/A was found to be associated with the occurrence of GC (adjusted OR: 1.91; 95% CI: 1.01-3.64). This study indicates that the LTA +252G allele is associated with increased risk for the presence of GC in a Helicobacter pylori infection positive subgroup and potential interaction between IL-10 and LTA may contribute to the risk of GC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / ethnology
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / microbiology
  • Adenocarcinoma / pathology
  • Aged
  • Asian People / genetics
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Helicobacter Infections / complications
  • Helicobacter Infections / ethnology
  • Helicobacter Infections / genetics*
  • Helicobacter Infections / pathology
  • Helicobacter pylori* / physiology
  • Heterozygote*
  • Humans
  • Lymphotoxin-alpha / genetics*
  • Male
  • Middle Aged
  • Point Mutation / physiology
  • Risk Factors
  • Stomach Neoplasms / ethnology
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / pathology

Substances

  • Lymphotoxin-alpha